Nine Diagnostics co-founders Daniel Heller and Mijin Kim are part of the Weill Cornell Medicine team led by Lish Ndhlovu contributing to the ARPA-H LIGHT program.
This program focuses on advancing the ability to measure and interpret signals from the lymphatic system — a historically under-characterized but critical component of human biology — using AI-enabled nanosensor technologies.
While the lymphatic system has been difficult to study directly, its role in immune regulation, metastasis, and disease progression makes it highly relevant to oncology. Improved measurement of lymphatic dynamics has the potential to unlock new insights into cancer progression, treatment response, and recurrence monitoring.
This work also contributes to broader technology validation and de-risking of nanosensor-based diagnostic approaches, demonstrating the ability to extract clinically meaningful signals from complex biological systems.
Link: Arpa-hLIGHT awardees
Link: CornellWeill Cornell Medicine Receives Funding to Develop Diagnostic Toolbox for Lymphatic Disease